Ladenburg initiated coverage of Autonomix with a Buy rating and $1.40 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMIX:
- Autonomix Medical, Inc. to Present at H.C. Wainwright 26th Annual Global Investment Conference
- Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2024 CIRSE Annual Congress
- Autonomix announces upcoming milestones
- Autonomix Medical, Inc. Reports First Quarter Fiscal Year 2025 Financial Results and Reiterates Near-Term Milestones
- Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment
Questions or Comments about the article? Write to editor@tipranks.com